Ritalin (methylphenidate) Full Prescribing Information DailyMed Drug Information Forms/Strengths Tablets: 5 mg, 10 mg, 20 mg  Dosing Age: ≥ 6 y/o Onset: ~ 20-60 min Duration: 3-4 hours Considerations: Abrupt onset and offset may increase the number and severity of side effects. Administer 30 to 45 minutes before meals. Initial Dose: Pediatric (6+ y/o): 5 mg twice daily (before breakfast and lunch) Adults: 10-15 mg twice or three times daily Titration: 5-10 mg weekly Max Dose: 60 mg/day Quick Facts Blocks dopamine/norepinephrine reuptake Enhances focus, attention, and impulse control Immediate-release formulation for rapid onset and short duration Available as tablets and oral solution for flexible dosing Common side effects: decreased appetite, insomnia, headache, gastrointestinal discomfort Indications  ADHD (ICD-10: F90.0) Off-Label Uses  N/A How to Take Take two to three times daily, with doses at least 4 hours apart. Can be taken with or without food; high-fat meals may delay absorption. Swallow the tablet whole; do not crush, chew, or split. Avoid taking late in the day to prevent insomnia. Side Effects Common: Insomnia, decreased appetite, weight loss, abdominal pain, headache, tachycardia Serious: Cardiovascular events, psychiatric symptoms, growth suppression, priapis Monitoring / Labs Cardiovascular: Baseline and routine monitoring of heart rate and blood pressure. Growth in Pediatrics: Regular monitoring of height and weight to detect growth suppression. Psychiatric Symptoms: Observe for mood changes, anxiety, or psychosis. Abuse Potential: Monitor for misuse or diversion. Education When to Call the Doctor: Severe mood changes, aggression, or suicidal thoughts. Chest pain, rapid heartbeat, shortness of breath (cardiovascular concerns). Uncontrolled movements, tics, or worsening anxiety. Numbness, coldness, or color changes in fingers or toes (circulatory issues). Unexplained weight loss or delayed growth in pediatric patients. Safety Tips: Monitor blood pressure and heart rate, especially in patients with cardiovascular risk. Use caution in patients with anxiety, bipolar disorder, or psychosis, as symptoms may worsen. Avoid caffeine and other stimulants, which may amplify side effects. Ensure adequate hydration and nutrition, as appetite suppression is common. Tapering may be required if discontinuing after long-term use. Parent Tips for Pediatric Patients: Encourage a nutrient-dense diet to counteract appetite suppression. Administer in the morning before school for optimal effect. Monitor school performance and behavioral changes. Observe for sleep disturbances; adjust timing if necessary. Communicate regularly with teachers and caregivers about medication effects. Additional Information Contraindications: Hypersensitivity to methylphenidate or formulation components. Use within 14 days of MAOI therapy (risk of hypertensive crisis). Symptomatic cardiovascular disease, moderate-to-severe hypertension, hyperthyroidism, glaucoma. History of substance use disorder, unless benefits outweigh risks. Pregnancy: Category C; use only if benefits outweigh risks. May cause neonatal withdrawal symptoms or low birth weight. Lactation: Excreted in breast milk; not recommended due to potential infant exposure. Drug Interactions: Serotonergic drugs (e.g., SSRIs, SNRIs, MAOIs) increase serotonin syndrome risk. Acidifying agents (e.g., ascorbic acid) may reduce drug absorption. Alkalinizing agents (e.g., sodium bicarbonate) may increase methylphenidate levels. May potentiate hypertensive effects of certain medications (e.g., decongestants, beta-agonists).